Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Lupus Erythematosus, Systemic"" wg kryterium: Temat


Tytuł:
Musculoskeletal symptoms in systemic lupus erythematosus patients and their impact on health-related quality of life.
Autorzy:
Tharwat S; Rheumatology & Immunology Unit, Department of Internal Medicine, Faculty of Medicine, Mansoura University, El Gomhouria St, Mansoura, Dakahlia Governorate, Egypt. .; Department of Internal Medicine, Faculty of Medicine, Horus University, New Damietta, Egypt. .
Husain SM; Mansoura Manchester Programme for Medical Education, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Pokaż więcej
Źródło:
BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2024 Apr 08; Vol. 25 (1), pp. 272. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/epidemiology
Musculoskeletal Pain*
Adult ; Male ; Female ; Humans ; Young Adult ; Quality of Life ; Cross-Sectional Studies ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Childhood adverse experiences and clinical manifestations in women with systemic lupus erythematosus.
Autorzy:
Esteves Rossini E; Faculty of Medicine, Federal University of Alagoas, Maceio, Brazil.
Lourival Zanoveli Cunha J; Department of Internal Medicine, Federal University of São Paulo, São Paulo, Brazil.
L B Costa G; Faculty of Medicine, CESMAC University Center, Maceio, Brazil.
Araujo Melo K; Faculty of Medicine, Federal University of Alagoas, Maceio, Brazil.
Cassemiro Micheleto JP; Faculty of Medicine, Federal University of Alagoas, Maceio, Brazil.
Miranda Pereira Fausto V; Faculty of Medicine, Federal University of Alagoas, Maceio, Brazil.
Quintiliano Pedroza L; Faculty of Medicine, Federal University of Alagoas, Maceio, Brazil.
Sotero Fragoso T; Department of Rheumatology, University Hospital Prof. Alberto Antunes, Maceio, Brazil.
Leão de Melo Neto V; Department of Psychiatry, University Hospital Prof. Alberto Antunes, Maceio, Brazil.
Cavalcante Oliveira MJ; Faculty of Medicine, Federal University of Alagoas, Maceio, Brazil.; Department of Medical Sciences, Federal University of Ceará, Fortaleza, Brazil; Department of Medical Sciences, Federal University of Alagoas, Maceio, Brazil.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (5), pp. 511-519. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/epidemiology
Lupus Erythematosus, Systemic*/diagnosis
Oral Ulcer*
Autoimmune Diseases*/complications
Psychological Tests*
Self Report*
Adult ; Humans ; Female ; Cross-Sectional Studies ; Observational Studies as Topic
SCR Protocol:
Childhood Trauma Questionnaire
Czasopismo naukowe
Tytuł:
Using combination of albumin to fibrinogen ratio and prognostic nutritional index model for predicting disease activity in patients with systemic lupus erythematosus.
Autorzy:
Zhao H; Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.; Jiangxi Medical College, Nanchang University, Nanchang, China.
Huang Z; Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Wang S; Jiangxi Medical College, Nanchang University, Nanchang, China.
Fu P; Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Fu B; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Guo Y; Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Li J; Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Luo Q; Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (5), pp. 490-501. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Nutrition Assessment*
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/complications
Humans ; Fibrinogen ; Prognosis ; Retrospective Studies ; Biomarkers ; Albumins
Czasopismo naukowe
Tytuł:
Comparison of late-onset and non-late-onset systemic lupus erythematosus individuals in a real-world electronic health record cohort.
Autorzy:
Adeogun G; Division of Rheumatology & Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Camai A; Division of Rheumatology & Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Suh A; Division of Rheumatology & Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Wheless L; Research Service, Tennessee Valley Healthcare System Veterans Administration Medical Center, Nashville, TN, USA.; Department of Dermatology, Division of Epidemiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Barnado A; Division of Rheumatology & Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (5), pp. 525-531. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/epidemiology
Lupus Nephritis*/diagnosis
Lupus Nephritis*/drug therapy
Lupus Nephritis*/epidemiology
Humans ; Female ; Middle Aged ; Male ; Electronic Health Records ; Age of Onset ; Autoantibodies/therapeutic use
Czasopismo naukowe
Tytuł:
Early add-on use of belimumab as induction therapy for patients with childhood-onset systemic lupus erythematosus.
Autorzy:
Hashimoto S; Department of Pediatrics, Hirosaki University Hospital, Hirosaki, Japan.
Fujita M; Department of Pediatrics, Hirosaki University Hospital, Hirosaki, Japan.
Aizawa T; Department of Pediatrics, Hirosaki University Hospital, Hirosaki, Japan.; Niji-iro Children's Clinic, Hirosaki, Japan.
Watanabe S; Department of Pediatrics, Hirosaki University Hospital, Hirosaki, Japan.; Department of Pediatrics, Ehime University Graduate School of Medicine, Toon City, Japan.
Tsugawa K; Department of Pediatrics, Hirosaki University Hospital, Hirosaki, Japan.
Tanaka H; Department of Pediatrics, Hirosaki University Hospital, Hirosaki, Japan.; Department of School Health Science, Hirosaki University Faculty of Education, Hirosaki, Japan.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (5), pp. 543-544. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Letter
MeSH Terms:
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/chemically induced
Humans ; Child ; Induction Chemotherapy ; Antibodies, Monoclonal, Humanized/therapeutic use ; Immunosuppressive Agents/therapeutic use ; Treatment Outcome
Opinia redakcyjna
Tytuł:
Comparison of the SLE Risk Probability Index (SLERPI) scale against the European League Against Rheumatism/American College of Rheumatology (ACR/EULAR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria.
Autorzy:
Castañeda-González JP; Research Institute, Fundación Universitaria de Ciencias de la Salud-FUCS, Bogotá, Colombia.
Mogollón Hurtado SA; Intensive Care Unit, Hospital San Rafael, Tunja, Colombia.
Rojas-Villarraga A; Research Institute, Fundación Universitaria de Ciencias de la Salud-FUCS, Bogotá, Colombia.
Guavita-Navarro D; Department of Rheumatology, Hospital de San José, Fundación Universitaria de Ciencias de la Salud-FUCS, Bogotá, Colombia.
Gallego-Cardona L; Department of Rheumatology, Hospital de San José, Fundación Universitaria de Ciencias de la Salud-FUCS, Bogotá, Colombia.
Arredondo AM; Department of Rheumatology, Hospital de San José, Fundación Universitaria de Ciencias de la Salud-FUCS, Bogotá, Colombia.
Cubides H; Department of Rheumatology, Hospital de San José, Fundación Universitaria de Ciencias de la Salud-FUCS, Bogotá, Colombia.
Ibáñez C; Research Institute, Fundación Universitaria de Ciencias de la Salud-FUCS, Bogotá, Colombia.
Escobar A; Department of Rheumatology, Hospital de San José, Fundación Universitaria de Ciencias de la Salud-FUCS, Bogotá, Colombia.
Cajamarca-Barón J; Research Institute, Fundación Universitaria de Ciencias de la Salud-FUCS, Bogotá, Colombia.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (5), pp. 520-524. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Rheumatology*
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/epidemiology
Rheumatic Diseases*
Humans ; Female ; United States ; Adult ; Male ; Antibodies, Antinuclear ; Adrenal Cortex Hormones
Czasopismo naukowe
Tytuł:
Life expectancy and death pattern associated with systemic lupus erythematosus diagnosis in Brazil between 2000 and 2019.
Autorzy:
Reis-Neto ETD; Division of Rheumatology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM / Unifesp), São Paulo, Brazil.
Monticielo OA; Division of Rheumatology, Department of Internal Medicine, Hospital de Clínicas de Porto Alegre, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil.
Daher M; Rheumatology, AstraZeneca, Cotia, Brazil.
Lopes F; Rheumatology, AstraZeneca, Cotia, Brazil.
Angrimani D; Rheumatology, AstraZeneca, Cotia, Brazil.
Klumb EM; Department of Rheumatology, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (5), pp. 536-542. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/epidemiology
Kidney Diseases*
Humans ; Brazil/epidemiology ; Life Expectancy ; Cause of Death
Czasopismo naukowe
Tytuł:
Impact of preeclampsia on infant and maternal health among women with rheumatic diseases.
Autorzy:
Milne ME; Division of Rheumatology & Immunology, Duke University School of Medicine, Durham, NC, USA.
Clowse ME; Division of Rheumatology & Immunology, Duke University School of Medicine, Durham, NC, USA.
Zhao C; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.
Goldstein BA; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.
Eudy AM; Division of Rheumatology & Immunology, Duke University School of Medicine, Durham, NC, USA.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (4), pp. 397-402. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Pre-Eclampsia*/epidemiology
Pre-Eclampsia*/prevention & control
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/epidemiology
Rheumatic Diseases*/complications
Rheumatic Diseases*/drug therapy
Rheumatic Diseases*/epidemiology
Pregnancy ; Infant, Newborn ; Infant ; Humans ; Female ; Adult ; Cohort Studies ; Retrospective Studies ; Maternal Health ; Pregnancy Outcome/epidemiology
Czasopismo naukowe
Tytuł:
Refractory lupus hepatitis successfully treated with telitacicept who failed to belimumab: A case report and literature review.
Autorzy:
Fan Q; Department of Immunology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ji H; Department of Dermatology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liu Y; Department of Immunology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jia C; Department of Immunology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zou L; Department of Immunology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yang H; Department of Immunology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (4), pp. 414-419. Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/drug therapy
Hepatitis*/drug therapy
Recombinant Fusion Proteins*
Antibodies, Monoclonal, Humanized*
Humans ; Prospective Studies ; Treatment Outcome ; Immunosuppressive Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort.
Autorzy:
Nieto R; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
Quintana R; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
Zavala-Flores E; Universidad Peruana Cayetano Heredia, Lima, Perú.
Serrano R; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
Roberts K; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
Catoggio LJ; Rheumatology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
García MA; Servicio de Reumatología, HIGA San Martin de La Plata, Buenos Aires, Argentina.
Berbotto GA; Servicio de Reumatología, Hospital Escuela 'Eva Perón', Granadero Baigorria, Argentina.
Saurit V; Servicio de Reumatología, Hospital Privado Universitario de Córdoba, Córdoba, Argentina.
Bonfa E; Rheumatology Division, Faculdade de Medicina, Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Borba EF; Rheumatology Division, Faculdade de Medicina, Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Lavras Costallat LT; Universidade Estadual da Campinas, Campinas, Brasil.
Da Silva NA; Servico de Reumatologia, Departamento de Clinica Medica, Faculdade de Medicina, Hospital das Clínicas,Universidade Federal de Goiás, Goiania, Brazil.
Sato EI; Escola Paulista de Medicina, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.
Tavares Brenol JC; Rheumatology Division, Department of Internal Medicine, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Massardo L; Centro de Biología Celular y Biomedicina (CEBICEM), Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago de Chile, Chile.
Neira OJ; Sección de Reumatología, Hospital del Salvador, Universidad de Chile, Unidad de Reumatología, Clínica Alemana de Santiago, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
Vázquez G; Grupo de Inmunología Celular e Inmunogenética, Universidad de Antioquia, Hospital Universitario, Fundación San Vicente, Medellín, Colombia.
Guibert Toledano M; Servicio Nacional de Reumatología, Centro de Investigaciones Médico Quirúrgicas (CIMEQ), La Habana, Cuba.
Pascual-Ramos V; Virginia Pascual-Ramos, Departamento de Inmunología y Reumatología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México DF, México.
Sauza Del Pozo MJ; Maria Josefina Sauza del Pozo, Laura E. Aranda Baca, and Adelfia Urenda Quezada, Servicio de Reumatología, Insti- tuto Mexicano de Seguro Social, Hospital de Especialidades No 25, Monterrey, México.
Barile-Fabris LA; Hospital Ángeles del Pedregal, México DF, México.
Amigo MC; Reumatología, Centro Médico ABC, México DF, México.
García De La Torre I; Departamento de Inmunología y Reumatología, Hospital General de Occidente de la S.S. y Universidad de Guadalajara, Zapopan, Jalisco, México.
Acevedo-Vásquez EM; Servicio de Reumatología, Hospital General Guillermo Almenara Irigoyen, EsSalud, Lima, Peru.
Segami MI; Servicio de Reumatología, Hospital General Guillermo Almenara Irigoyen, EsSalud, Lima, Peru.
Chacón-Díaz R; Servicio de Reumatología, Policlínica Méndez Gimón, Caracas, Venezuela.
Esteva-Spinetti MH; Servicio de Reumatología, Departamento de Medicina, Hospital Central de San Cristóbal, San Cristóbal, Venezuela.
Alarcón GS; Universidad Peruana Cayetano Heredia, Lima, Perú.; The University of Alabama at Birmingham Marnix E. Heersink School of Medicine, Birmingham, AL, USA.
Pons-Estel BA; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
Pons-Estel GJ; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (4), pp. 340-346. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/complications
Humans ; Female ; Prednisone/therapeutic use ; Latin America/epidemiology ; Disease Progression ; Hispanic or Latino ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score.
Autorzy:
Labouret M; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.; Sorbonne Université, Paris, France.
Trebossen V; Department of Child and Adolescent Psychiatry, Robert Debré Mother-Child University Hospital, AP-HP, Paris, France.; Université Paris Cité, UFR de Médecine Paris Nord, Paris, France.
Ntorkou A; Department of Paediatric Radiology, Robert Debré Mother-Child University Hospital, AP-HP, Paris, France.
Bartoli S; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
Aubart M; Paediatric Neurology Department, Necker-Enfants Malades Hospital, University of Paris-Cité, AP-HP, Paris, France.; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, French Institute of Health and Medical Research U1163, Imagine Institute, University of Paris-Cité, Paris, France.
Auvin S; Department of Paediatric Neurology, Center for Rare Epilepsies & Epilepsy Unit, Robert Debré Mother-Child University Hospital, AP-HP, Paris, France.; Université Paris Cité, INSERM NeuroDiderot, Paris, France.; Institut Universitaire de France (IUF), Paris, France.
Bader-Meunier B; Department of Paediatric Haematology-Immunology And Rheumatology, Necker-Enfants-Malades University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.; Laboratory of Immunogenetics of Paediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Université Paris Cité, Paris, France.
Baudouin V; Department of Paediatric Nephrology, Robert Debré Mother-Child University Hospital, AP-HP, Paris, France.
Corseri O; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
Dingulu G; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
Ducrocq C; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
Dumaine C; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
Elmaleh M; Department of Paediatric Radiology, Robert Debré Mother-Child University Hospital, AP-HP, Paris, France.
Fabien N; Immunology Department, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Lyon, France.
Faye A; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.; Université Paris Cité, UFR de Médecine Paris Nord, Paris, France.; UMR1123 Inserm, Université Paris Cité, Paris, France.
Hau I; Department of General Paediatrics, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
Hentgen V; Department of General Paediatrics, French Reference centre for Autoinflammatory diseases and amyloidosis (CEREMAIA), Versailles Hospital, Le Chesnay, France.
Kwon T; Department of Paediatric Nephrology, Robert Debré Mother-Child University Hospital, AP-HP, Paris, France.
Meinzer U; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.; Université Paris Cité, UFR de Médecine Paris Nord, Paris, France.; Center for Research on Inflammation, INSERM, Université Paris Cité, Paris, France.; Biology and Genetics of Bacterial Cell Wall Unit, Pasteur Institute, Paris, France.
Ouldali N; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.; Université Paris Cité, UFR de Médecine Paris Nord, Paris, France.
Parmentier C; Department of Paediatric Nephrology, Armand-Trousseau Childrens' Hospital, AP-HP, Paris, France.
Pouletty M; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
Renaldo F; Department of Paediatric Neurology, Center for Neurogenetic Diseases, Armand-Trousseau Childrens' Hospital, AP-HP, Paris, France.
Savioz I; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.
Benoist JF; Metabolic Biochemistry Laboratory, Reference Centre for Inherited Metabolic Diseases, Necker-Enfants-Malades University Hospital, AP-HP, Paris, France.; Université Paris Saclay, UFR Pharmacie, France.
Le Roux E; UMR1123 Inserm, Université Paris Cité, Paris, France.; Unité d'Épidémiologie Clinique, Inserm, CIC 1426, Robert Debré Mother-Child University Hospital, Nord-Université Paris Cité, AP-HP, Paris, France.
Ellul P; Department of Child and Adolescent Psychiatry, Robert Debré Mother-Child University Hospital, AP-HP, Paris, France.; Immunology-Immunopathology-Immunotherapy (i3), Sorbonne Université, Paris, France.
Melki I; General Paediatrics, Department of Infectious Disease and Internal Medicine, Robert Debré Mother-Child University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.; Department of Paediatric Haematology-Immunology And Rheumatology, Necker-Enfants-Malades University Hospital, Reference Centre for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), AP-HP, Paris, France.; Imagine Institute, Laboratory of Neurogenetics and Neuroinflammation, INSERM UMR 1163, Université Paris Cité, Paris, France.; Paediatrics, Rheumatology and Paediatric Internal Medicine, Children's Hospital, Bordeaux, France.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (4), pp. 328-339. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Vasculitis, Central Nervous System*/pathology
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/pathology
Humans ; Child ; Retrospective Studies ; Brain/diagnostic imaging ; Brain/pathology ; Magnetic Resonance Imaging/methods ; Hallucinations/complications ; Hallucinations/pathology
Czasopismo naukowe
Tytuł:
Factors affecting different COVID-19 outcomes in patients with systemic lupus erythematosus during the second pandemic wave of COVID-19 in China.
Autorzy:
Liu PC; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Zhang M; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Li JB; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Peng YL; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Yu SJ; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Wu R; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (4), pp. 357-364. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/epidemiology
Lupus Erythematosus, Systemic*/complications
COVID-19*/epidemiology
COVID-19*/complications
Humans ; Retrospective Studies ; Pandemics ; COVID-19 Vaccines
Czasopismo naukowe
Tytuł:
Neutrophilic dermatoses as a manifestation of a systemic lupus erythematosus flare.
Autorzy:
Wang Y; Department of Internal Medicine, UCI Medical Center, Orange, CA, USA.
Chen E; Division of Rheumatology, UCI Medical Center, Orange, CA, USA.
Iyer P; Division of Rheumatology, UCI Medical Center, Orange, CA, USA.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Apr; Vol. 33 (4), pp. 409-413. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/diagnosis
Skin Diseases*/pathology
Autoimmune Diseases*/complications
Sjogren's Syndrome*/complications
Sjogren's Syndrome*/diagnosis
Humans ; Skin/pathology
Czasopismo naukowe
Tytuł:
Exploring paediatric rheumatology care: a ten-year retrospective analysis of the patient population in Ghana.
Autorzy:
Dey D; Rheumatology Unit, Department of Medicine and Therapeutics, University of Ghana Medical School Legon-Accra, Accra, Ghana. .; Rheumatology Unit, Department of Medicine and Therapeutics, Korle Bu Teaching Hospital, Accra, Ghana. .
Katso B; Rheumatology Unit, Department of Medicine and Therapeutics, Korle Bu Teaching Hospital, Accra, Ghana.
Baah A; Department of Medicine and Therapeutics, Korle Bu Teaching Hospital, Accra, Ghana.
Isaaka S; Rheumatology Unit, Department of Medicine and Therapeutics, Korle Bu Teaching Hospital, Accra, Ghana.
Amoako E; Department of Paediatrics, Korle Bu Teaching Hospital, Accra, Ghana.
Pokaż więcej
Źródło:
Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2024 Mar 21; Vol. 22 (1), pp. 40. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Journal Article
MeSH Terms:
Rheumatology*
Rheumatic Diseases*/epidemiology
Rheumatic Diseases*/therapy
Rheumatic Diseases*/diagnosis
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/epidemiology
Lupus Erythematosus, Systemic*/therapy
Adult ; Female ; Humans ; Child ; Adolescent ; Male ; Ghana/epidemiology ; Retrospective Studies ; Quality of Life ; Health Services Accessibility
Czasopismo naukowe
Tytuł:
A single-agent fusion of human IL-2 and anti-IL-2 antibody that selectively expands regulatory T cells.
Autorzy:
Lin Y; Shanghai Shengdi Pharmaceutical Co. Ltd, Shanghai, 200100, China.; Jiangsu Hengrui Pharmaceutical Co. Ltd, Lianyungang, 222000, China.
Wang X; Shanghai Shengdi Pharmaceutical Co. Ltd, Shanghai, 200100, China.; Jiangsu Hengrui Pharmaceutical Co. Ltd, Lianyungang, 222000, China.
Qin Y; Shanghai Shengdi Pharmaceutical Co. Ltd, Shanghai, 200100, China.; Jiangsu Hengrui Pharmaceutical Co. Ltd, Lianyungang, 222000, China.
Wang C; Shanghai Shengdi Pharmaceutical Co. Ltd, Shanghai, 200100, China.; Jiangsu Hengrui Pharmaceutical Co. Ltd, Lianyungang, 222000, China.
Zhou T; Shanghai Shengdi Pharmaceutical Co. Ltd, Shanghai, 200100, China.; Jiangsu Hengrui Pharmaceutical Co. Ltd, Lianyungang, 222000, China.
Zhang L; Shanghai Shengdi Pharmaceutical Co. Ltd, Shanghai, 200100, China.; Jiangsu Hengrui Pharmaceutical Co. Ltd, Lianyungang, 222000, China.
Su L; Shanghai Shengdi Pharmaceutical Co. Ltd, Shanghai, 200100, China.; Jiangsu Hengrui Pharmaceutical Co. Ltd, Lianyungang, 222000, China.
Ren W; Shanghai Shengdi Pharmaceutical Co. Ltd, Shanghai, 200100, China.; Jiangsu Hengrui Pharmaceutical Co. Ltd, Lianyungang, 222000, China.
Liao C; Shanghai Shengdi Pharmaceutical Co. Ltd, Shanghai, 200100, China. .; Jiangsu Hengrui Pharmaceutical Co. Ltd, Lianyungang, 222000, China. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2024 Mar 09; Vol. 7 (1), pp. 299. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/therapy
T-Lymphocytes, Regulatory*
Antibodies*/pharmacology
Antibodies*/therapeutic use
Animals ; Humans ; Autoimmune Diseases/drug therapy ; Autoimmune Diseases/therapy ; Cytokines ; Interleukin-2/immunology
Czasopismo naukowe
Tytuł:
Diagnosis of multiple tuberculous muscle abscesses in a patient with systemic lupus erythematosus by metagenomic next-generation sequencing- a case report and literature review.
Autorzy:
Wentao L; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Shuxia X; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Guoxing Z; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Qiaoping C; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Peiran C; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Angela W; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Meirong L; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Songchao Y; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Peiying F; Department of Dermatology, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. .; Department of Allergy, 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 04; Vol. 24 (1), pp. 284. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Dermatomyositis*/complications
Dermatomyositis*/diagnosis
Tuberculosis*/complications
Tuberculosis*/diagnosis
Tuberculosis*/drug therapy
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/diagnosis
Female ; Humans ; Adult ; Abscess/diagnosis ; Muscles ; High-Throughput Nucleotide Sequencing ; Streptomycin
Czasopismo naukowe
Tytuł:
Systemic lupus erythematosus with chronic persistent intracranial hypertension: A case report.
Autorzy:
Zou M; Department of Rheumatology and Immunology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Jiang X; Department of Radiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Chen H; Department of Rheumatology and Immunology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Yuan F; Department of Rheumatology and Immunology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Mar; Vol. 33 (3), pp. 293-297. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/drug therapy
Papilledema*/complications
Papilledema*/drug therapy
Intracranial Hypertension*/diagnosis
Intracranial Hypertension*/etiology
Intracranial Hypertension*/drug therapy
Humans ; Acetazolamide/therapeutic use ; Headache/etiology
Czasopismo naukowe
Tytuł:
Analysis of clinical, immunological characteristics, damage, and survival in 300 Turkish systemic lupus erythematosus patients.
Autorzy:
Tekeoglu S; Department of Rheumatology, Internal Medicine, Halic University, Istanbul, Turkey.
Temiz Karadag D; Department of Rheumatology, Internal Medicine, Kocaeli University, Kocaeli, Turkey.
Ozdemir Isik O; Department of Rheumatology, Internal Medicine, Kocaeli University, Kocaeli, Turkey.
Yazici A; Department of Rheumatology, Internal Medicine, Kocaeli University, Kocaeli, Turkey.
Cefle A; Department of Rheumatology, Internal Medicine, Kocaeli University, Kocaeli, Turkey.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Mar; Vol. 33 (3), pp. 298-311. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/epidemiology
Lupus Erythematosus, Systemic*/diagnosis
Lupus Nephritis*
Renal Insufficiency, Chronic*
Exanthema*
Humans ; Female ; Adolescent ; Male ; Retrospective Studies
SCR Disease Name:
malar rash
Czasopismo naukowe
Tytuł:
Regarding the efficacy of the COVID-19 vaccine in pediatric systemic lupus erythematosus patient.
Autorzy:
Cui W; Department of Clinical Laboratory, XianJu People's Hospital, Zhejiang Southeast Campus of Zhejiang Provincial People's Hospital, Affiliated Xianju's Hospital, Hangzhou Medical College, Xianju Zhejiang, China.
Zhang Y; Department of Anesthesiology, Xinchang Hospital Affiliated to Wenzhou Medical University, Xinchang, China.
Shen Y; Department of Clinical Laboratory, XianJu People's Hospital, Zhejiang Southeast Campus of Zhejiang Provincial People's Hospital, Affiliated Xianju's Hospital, Hangzhou Medical College, Xianju Zhejiang, China.; Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Mar; Vol. 33 (3), pp. 312-313. Date of Electronic Publication: 2024 Jan 15.
Typ publikacji:
Letter
MeSH Terms:
COVID-19*/prevention & control
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/drug therapy
Child ; Humans ; COVID-19 Vaccines/administration & dosage
Opinia redakcyjna
Tytuł:
Rhupus syndrome in children: A multi-center retrospective cohort study and literature review.
Autorzy:
Sener S; Department of Pediatrics, Division of Pediatric Rheumatology, Hacettepe University Faculty of Medicine Ankara, Turkey.
Batu ED; Department of Pediatrics, Division of Pediatric Rheumatology, Hacettepe University Faculty of Medicine Ankara, Turkey.
Sahin S; Department of Pediatrics, Department of Pediatric Rheumatology, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey.
Yildirim DG; Department of Pediatrics, Department of Pediatric Rheumatology, Gazi University Faculty of Medicine, Ankara, Turkey.
Ekinci MK; Department of Pediatrics, Department of Pediatric Rheumatology, Adana City Training and Research Hospital, Adana, Turkey.
Kisaoglu H; Department of Pediatrics, Department of Pediatric Rheumatology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey.
Karali Y; Department of Pediatrics, Division of Immunology and Rheumatology, Uludag University Faculty of Medicine, Bursa, Turkey.
Demir S; Department of Pediatrics, Department of Pediatric Rheumatology, Eskisehir Osmangazi University, Ankara, Turkey.
Kaya Akca U; Department of Pediatrics, Division of Pediatric Rheumatology, Aydin Gynecology and Children's Hospital, Aydın, Turkey.
Gunalp A; Department of Pediatrics, Department of Pediatric Rheumatology, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey.
Turkmen S; Department of Pediatrics, Division of Pediatric Rheumatology, Umraniye Training and Research Hospital, Istanbul, Turkey.
Kavrul Kayaalp G; Department of Pediatrics, Department of Pediatric Rheumatology, Istanbul University Faculty of Medicine, Istanbul, Turkey.
Arslanoglu C; Department of Pediatrics, Division of Pediatric Rheumatology, Erciyes University Faculty of Medicine, Kayseri, Turkey.
Torun R; Department of Pediatrics, Department of Pediatric Rheumatology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey.
Basaran O; Department of Pediatrics, Division of Pediatric Rheumatology, Hacettepe University Faculty of Medicine Ankara, Turkey.
Pac Kisaarslan A; Department of Pediatrics, Division of Pediatric Rheumatology, Erciyes University Faculty of Medicine, Kayseri, Turkey.
Sozeri B; Department of Pediatrics, Division of Pediatric Rheumatology, Umraniye Training and Research Hospital, Istanbul, Turkey.
Aktay Ayaz N; Department of Pediatrics, Department of Pediatric Rheumatology, Istanbul University Faculty of Medicine, Istanbul, Turkey.
Bakkaloglu SA; Department of Pediatrics, Department of Pediatric Rheumatology, Gazi University Faculty of Medicine, Ankara, Turkey.
Kilic SS; Department of Pediatrics, Division of Immunology and Rheumatology, Uludag University Faculty of Medicine, Bursa, Turkey.
Kalyoncu M; Department of Pediatrics, Department of Pediatric Rheumatology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey.
Bilginer Y; Department of Pediatrics, Division of Pediatric Rheumatology, Hacettepe University Faculty of Medicine Ankara, Turkey.
Unsal E; Department of Pediatrics, Department of Pediatric Rheumatology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey.
Kasapcopur O; Department of Pediatrics, Department of Pediatric Rheumatology, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey.
Ozen S; Department of Pediatrics, Division of Pediatric Rheumatology, Hacettepe University Faculty of Medicine Ankara, Turkey.
Pokaż więcej
Źródło:
Lupus [Lupus] 2024 Mar; Vol. 33 (3), pp. 273-281. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/drug therapy
Arthritis, Rheumatoid*/complications
Arthritis, Juvenile*/complications
Arthritis, Juvenile*/drug therapy
Humans ; Child ; Hydroxychloroquine/therapeutic use ; Retrospective Studies ; Methotrexate/therapeutic use ; Glucocorticoids/therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Multicenter Studies as Topic
SCR Disease Name:
rhupus syndrome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies